Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Aurobindo Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs 1112, up 1.15% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.56% on the day, quoting at 26080.4. The Sensex is at 85005.24, up 0.45%. Aurobindo Pharma Ltd has risen around 2.59% in last one month.
Meanwhile, Nifty Pharma index of which Aurobindo Pharma Ltd is a constituent, has risen around 4.61% in last one month and is currently quoting at 22250.9, up 0.87% on the day. The volume in the stock stood at 8.82 lakh shares today, compared to the daily average of 11.47 lakh shares in last one month.
The benchmark November futures contract for the stock is quoting at Rs 1121.2, up 1.33% on the day. Aurobindo Pharma Ltd is down 20.86% in last one year as compared to a 7.15% spurt in NIFTY and a 0.31% spurt in the Nifty Pharma index.
The PE of the stock is 32.59 based on TTM earnings ending June 25.
The subsidiary has been incorporated with an initial share capital of CLP 1,000,000 (approximately USD 1,050), divided into 100 shares with a nominal value of CLP 10,000 each. Eugia Pharma B.V. has subscribed to 100% of the share capital in cash, thereby holding full ownership of the Chilean entity.
Aurobindo Pharma is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services.
The company’s consolidated net profit tumbled 10.3% to Rs 824.75 crore despite a 4.5% increase in revenue from operations to Rs 7791.77 crore in Q1 FY26 over Q1 FY25.